Regeneron (REGN)
NASDAQ:REGN

Regeneron (REGN) Stock Price & Analysis

3,707 Followers

REGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$668.00 - $853.97
Previous Close$836.85
Volume383.87K
Average Volume (3M)481.01K
Market Cap
$89.33B
Enterprise Value$83.10B
Total Cash (Recent Filing)$8.93B
Total Debt (Recent Filing)$2.70B
Price to Earnings (P/E)22.1
Beta0.66
Nov 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)37.84
Shares Outstanding108,558,718
10 Day Avg. Volume348,841
30 Day Avg. Volume481,011
Standard Deviation0.09
R-Squared0.01
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)3.95
Price to Sales (P/S)28.29
Price to Cash Flow (P/CF)22.30
P/FCF Ratio24.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.56
Enterprise Value/Gross Profit8.02
Enterprise Value/Ebitda15.86
Forecast
Price Target Upside10.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

REGN FAQ

What was Regeneron’s price range in the past 12 months?
Regeneron lowest stock price was $668.00 and its highest was $853.97 in the past 12 months.
    What is Regeneron’s market cap?
    Currently, no data Available
    When is Regeneron’s upcoming earnings report date?
    Regeneron’s upcoming earnings report date is Nov 02, 2023 which is in 14 days.
      How were Regeneron’s earnings last quarter?
      Regeneron released its earnings results on Aug 03, 2023. The company reported $10.24 earnings per share for the quarter, beating the consensus estimate of $9.847 by $0.393.
        Is Regeneron overvalued?
        According to Wall Street analysts Regeneron’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Regeneron pay dividends?
          Regeneron does not currently pay dividends.
          What is Regeneron’s EPS estimate?
          Regeneron’s EPS estimate is $10.74.
            How many shares outstanding does Regeneron have?
            Regeneron has 106,740,570 shares outstanding.
              What happened to Regeneron’s price movement after its last earnings report?
              Regeneron reported an EPS of $10.24 in its last earnings report, beating expectations of $9.847. Following the earnings report the stock price went up 5.372%.
                Which hedge fund is a major shareholder of Regeneron?
                Among the largest hedge funds holding Regeneron’s share is Dodge & Cox. It holds Regeneron’s shares valued at 2B.

                  ---

                  Regeneron Stock Smart Score

                  The Regeneron stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Regeneron

                  Founded in 1988, Regeneron Pharmaceuticals, Inc. is a New York-based biotechnology company, which discovers, develops, manufactures, and commercializes medicines for the treatment of various medical conditions. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.

                  ---

                  Top 5 ETFs holding REGN

                  Name
                  Market Value
                  Smart Score
                  Global X S&P 500 Covered Call ETF
                  $6.98M
                  8
                  iShares ESG Screened S&P 500 ETF
                  $430.73K
                  8
                  Global X S&P 500 Covered Call & Growth ETF
                  $146.74K
                  8
                  Global X S&P 500 ESG Covered Call ETF
                  $8.44K
                  8
                  Global X S&P 500 Tail Risk ETF
                  $5.87K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold REGN. The ETFs are listed according to market value of REGN within the ETF

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Amgen
                  AbbVie
                  Vertex Pharmaceuticals
                  Biogen

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis